80 Followers on Owler
Ocular is a Massachusetts-based biopharmaceutical company that researches and develops novel therapies for the treatment of ocular diseases... Read more
OverviewCompetitorsFundingNews & Insights
Ocular is a Massachusetts-based biopharmaceutical company that researches and develops novel therapies for the treatment of ocular diseases... Read more
Ocular Therapeutix Chairman & CEO: Pravin U. Dugel

Chairman & CEO

Pravin U. Dugel

CEO Approval Rating

85/100

2006

PublicMerger Pending with Ocuvex Therapeutics, IncNASDAQOCUL

Pharmaceuticals & Biotechnology
Pharmaceuticals
28342836 NAICS listing

Annual Revenue
$52.1M
Employees
230
Funding
$663.9M

News

Conference Presentation
Apr 27, 2026
Benzinga
Ocular Therapeutix to Participate in May Scientific and Investor Conferences
Funding
Oct 31, 2025
Robert W. Baird & Co. Incorporated.
Ocular received $475M in Post-IPO Equity Funding

Ocular Therapeutix Competitors

1Clearside Biomedical
2AbbVie
3Kala Bio
4ONL Therapeutics
5Mati Therapeutics
6Innoviz
7EyePoint
8Shire
9Quethera
10MacuCLEAR
Unlock 8 + competitors

Trending Companies